Literature DB >> 699382

Thromboxane B2 inhibits prostaglandin E2 inactivation by the rat isolated perfused lung.

A L Boura, R D Murphy.   

Abstract

1. The effect of thromboxane B2 (TxB2) on inactivation of prostaglandin E2 (PGE2) by the rat isolated perfused lung has been studied. 2. TxB2 when infused in low concentrations (100 ng/ml) into the pulmonary artery reduced PGE2 inactivation approximately two-fold. 3. The rat isolated fundus strip was contracted by higher concentrations of TxB2 (1.0 microgram/ml) in the presence of hyoscine, mepyramine, methysergide, phenoxybenzamine and propranolol. The size of contraction was reduced by indomethacin in concentrations known to inhibit prostaglandin synthetase. 4. Thus, in circumstances in which TxB2 and PGE2 are released concomitantly by the lung, low concentrations of TxB2 may augment PGE2 release by reducing its inactivation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699382     DOI: 10.1111/j.1440-1681.1978.tb00688.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Stimulating effect of thromboxane B2 on isolated rat atria.

Authors:  L Sterin-Borda; L Canga; A L Gimeno
Journal:  Experientia       Date:  1981-06

2.  Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog.

Authors:  T M Fitzpatrick; L S Friedman; P A Kot; P W Ramwell
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.